337 related articles for article (PubMed ID: 31347405)
1. Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials.
Molfino A; Amabile MI; Giorgi A; Monti M; D'Andrea V; Muscaritoli M
Expert Opin Investig Drugs; 2019 Aug; 28(8):733-740. PubMed ID: 31347405
[No Abstract] [Full Text] [Related]
2. Phase II drugs that are currently in development for the treatment of cachexia.
Dingemans AM; de Vos-Geelen J; Langen R; Schols AM
Expert Opin Investig Drugs; 2014 Dec; 23(12):1655-69. PubMed ID: 25056249
[TBL] [Abstract][Full Text] [Related]
3. New developments in investigational HDAC inhibitors for the potential multimodal treatment of cachexia.
Penna F; Costelli P
Expert Opin Investig Drugs; 2019 Feb; 28(2):179-189. PubMed ID: 30526137
[TBL] [Abstract][Full Text] [Related]
4. Advances in pharmacologic strategies for cancer cachexia.
Madeddu C; Mantovani G; Gramignano G; Macciò A
Expert Opin Pharmacother; 2015; 16(14):2163-77. PubMed ID: 26330024
[TBL] [Abstract][Full Text] [Related]
5. Novel investigational drugs mimicking exercise for the treatment of cachexia.
Penna F; Pin F; Ballarò R; Baccino FM; Costelli P
Expert Opin Investig Drugs; 2016; 25(1):63-72. PubMed ID: 26560328
[TBL] [Abstract][Full Text] [Related]
6. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
Crawford J; Prado CM; Johnston MA; Gralla RJ; Taylor RP; Hancock ML; Dalton JT
Curr Oncol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138015
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cachexia: an overview of recent developments.
von Haehling S; Anker SD
J Am Med Dir Assoc; 2014 Dec; 15(12):866-72. PubMed ID: 25455531
[TBL] [Abstract][Full Text] [Related]
8. Novel treatments for cancer cachexia.
Bossola M; Pacelli F; Doglietto GB
Expert Opin Investig Drugs; 2007 Aug; 16(8):1241-53. PubMed ID: 17685872
[TBL] [Abstract][Full Text] [Related]
9. Novel investigational biologics for the treatment of cancer cachexia.
Ma JD; Heavey SF; Revta C; Roeland EJ
Expert Opin Biol Ther; 2014 Aug; 14(8):1113-20. PubMed ID: 24707881
[TBL] [Abstract][Full Text] [Related]
10. The potential of ghrelin in the treatment of cancer cachexia.
Argilés JM; Stemmler B
Expert Opin Biol Ther; 2013 Jan; 13(1):67-76. PubMed ID: 23078025
[TBL] [Abstract][Full Text] [Related]
11. Enobosarm (GTx-024, S-22): a potential treatment for cachexia.
Srinath R; Dobs A
Future Oncol; 2014 Feb; 10(2):187-94. PubMed ID: 24490605
[TBL] [Abstract][Full Text] [Related]
12. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.
Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J
Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795
[TBL] [Abstract][Full Text] [Related]
13. Clinical results in cachexia therapeutics.
Crawford J
Curr Opin Clin Nutr Metab Care; 2016 May; 19(3):199-204. PubMed ID: 26974316
[TBL] [Abstract][Full Text] [Related]
14. Multitargeted treatment of cancer cachexia.
Madeddu C; Maccio A; Mantovani G
Crit Rev Oncog; 2012; 17(3):305-14. PubMed ID: 22831161
[TBL] [Abstract][Full Text] [Related]
15. An update on promising agents for the treatment of cancer cachexia.
Madeddu C; Mantovani G
Curr Opin Support Palliat Care; 2009 Dec; 3(4):258-62. PubMed ID: 19667995
[TBL] [Abstract][Full Text] [Related]
16. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
[TBL] [Abstract][Full Text] [Related]
17. Editorial update on emerging drugs for cancer cachexia.
Murphy KT; Lynch GS
Expert Opin Emerg Drugs; 2012 Mar; 17(1):5-9. PubMed ID: 22229463
[TBL] [Abstract][Full Text] [Related]
18. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
19. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
20. Cancer cachexia: it's time for more clinical trials.
Bossola M; Pacelli F; Tortorelli A; Doglietto GB
Ann Surg Oncol; 2007 Feb; 14(2):276-85. PubMed ID: 17094025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
